OrganiGram Holdings Inc (OGI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $102.17M
Last updated: Nov 17, 2026 at 4:41 PM ET
OrganiGram Holdings Inc (OGI) Statistics
OrganiGram Holdings (OGI) has a market cap of $102.17M. Revenue grew 38.11% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $102.17M |
|---|---|
| Latest price (Nov 17, 2026) | $0.71 |
Key Dates
The next earnings report is expected on Dec 15, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Dec 15, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 11, 2026 |
| Fiscal Year End | September |
Valuation Ratios
Sales and book value multiples are 0.4x and 0.2x. Its year-end P/S ranged from 0.9x to 43.9x from 2017 to 2025.
| P/S Ratio | 0.4x |
|---|---|
| P/B Ratio | 0.2x |
| P/TBV Ratio | 0.9x |
Price Statistics
The stock is down 53.19% over 52 weeks and trades 26.80% below its 50-day average.
| Beta (1Y) | 1.09 |
|---|---|
| 52-Week Change | -53.19% |
| 1-Month Change | -25.01% |
| 3-Month Change | -42.99% |
| 6-Month Change | -32.03% |
| 5-Year Change | -89.44% |
| 10-Year Change | -88.89% |
| Total Return (1Y) | -53.19% |
| Total Return (3Y CAGR) | -17.52% |
| Total Return (5Y CAGR) | -38.56% |
| Max Drawdown (1Y) | -66.50% |
| Max Drawdown (3Y) | -74.01% |
| Sharpe Ratio (1Y) | -1.36 |
| Correlation with SPY (1Y) | 0.26 |
| 50-Day Average | $0.97 |
| 200-Day Average | $1.16 |
| 52-Week Range | $0.71 to $2.24 |
| RSI (14 Days) | 20.9 |
| Average Volume (20 Days) | 679.40K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.61x current liabilities, and total debt is 0.04x shareholder equity.
| Current Ratio | 2.61x |
|---|---|
| Quick Ratio | 1.07x |
| Debt / Equity | 0.04x |
| Debt / EBITDA | 1.13x |
Returns and Efficiency
Return on invested capital is -1.21% over the last 12 months, against a 5-year average of -12.19%.
| Return on Equity (ROE) | 15.55% |
|---|---|
| Return on Assets (ROA) | 10.55% |
| Return on Invested Capital (ROIC) | -1.21% |
| ROE (5Y Average) | -26.90% |
| ROA (5Y Average) | -23.45% |
| ROIC (5Y Average) | -12.19% |
| Asset Turnover | 0.45x |
| Inventory Turnover | 1.31x |
| Receivables Turnover | 4.39x |
| Cash Conversion Cycle | 201 days |
Scores
OGI has an Altman Z-Score of 0.09, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.09 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was CAD 309.12M over the last 12 months.
| Revenue | CAD 309.12M |
|---|---|
| Revenue Growth (YoY) | +38.11% |
| Gross Profit | CAD 112.98M |
| Operating Income | CAD -6.69M |
| Pretax Income | CAD 81.25M |
| Net Income | CAD 86.61M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 67.85% of the CAD 820.26M in total assets.
| Working Capital | CAD 172.81M |
|---|---|
| Shareholder Equity | CAD 556.52M |
| Tangible Book Value | CAD 158.30M |
| Total Assets | CAD 820.26M |
| Total Liabilities | CAD 263.74M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After CAD 3.55M of capital spending, operating cash flow left CAD -32.07M of free cash flow.
| Operating Cash Flow | CAD -28.52M |
|---|---|
| Capital Expenditures | CAD 3.55M |
| Free Cash Flow | CAD -32.07M |
| Depreciation and Amortization | CAD 25.10M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -2.16%, against a 5-year average of -67.42%.
| Gross Margin | 36.55% |
|---|---|
| Operating Margin | -2.16% |
| Pretax Margin | 26.29% |
| Net Margin | 28.02% |
| FCF Margin | -10.37% |
| Gross Margin (5Y Average) | 8.54% |
| Operating Margin (5Y Average) | -67.42% |
| Net Margin (5Y Average) | -73.34% |
Growth
Revenue grew 8.47% a year over 3 years.
| Revenue Growth (3Y CAGR) | +8.47% |
|---|---|
| Revenue Growth (5Y CAGR) | +16.48% |
Stock Splits
The last split was a 1-for-4 reverse split on Jul 7, 2023.
| Last Split Date | Jul 7, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:4 |
Peer Position
Against 7 similar companies, OGI has the 6th highest P/S.
P/S RatioPeer median 1.4x
ROICPeer median -21.87%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.06%
| P/S Ratio | 0.4x vs 1.4x median |
|---|---|
| ROIC | -1.21% vs -21.87% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +38.11% vs +10.06% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OGI
What is OGI's market cap?
OrganiGram Holdings has a market cap of $102.17M.
How many shares of OGI are outstanding?
OrganiGram Holdings has 136.53M shares outstanding. The count is up 1.95% from a year earlier.
Does OGI pay a dividend?
No. OrganiGram Holdings does not pay a dividend.
OGI pages: Overview, Charting, Financials, Statistics, Valuation, Competitors